T1	DISO 95 111	colitis ulcerosa
#1	AnnotatorNotes T1	C0009324; Ulcerative Colitis; Disease or Syndrome
T2	PROC 159 217	Estudio multicéntrico, doble ciego, controlado con placebo
T3	CHEM 258 265	ABT 494
#2	AnnotatorNotes T3	C4308782; ABT-494; Organic Chemical · Pharmacologic Substance
T4	PROC 223 254	evaluar la seguridad y eficacia
T5	PROC 274 314	tratamiento de inducción y mantenimiento
#3	AnnotatorNotes T5	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure + C0857127; Induction procedure; Therapeutic or Preventive Procedure
T6	DISO 332 348	Colitis Ulcerosa
#4	AnnotatorNotes T6	C0009324; Ulcerative Colitis; Disease or Syndrome
T7	DISO 392 408	Colitis Ulcerosa
#5	AnnotatorNotes T7	C0009324; Ulcerative Colitis; Disease or Syndrome
T8	PROC 495 509	Diagnosticados
#6	AnnotatorNotes T8	C0011900; Diagnosis; Diagnostic Procedure
T9	DISO 514 530	colitis ulcerosa
#7	AnnotatorNotes T9	C0009324; Ulcerative Colitis; Disease or Syndrome
T10	PROC 592 604	colonoscopia
#8	AnnotatorNotes T10	C0009378; colonoscopy; Diagnostic Procedure
T11	DISO 609 625	Colitis ulcerosa
#9	AnnotatorNotes T11	C0009324; Ulcerative Colitis; Disease or Syndrome
T12	DISO 711 723	intolerancia
#10	AnnotatorNotes T12	C0277585; Intolerance to drug; Pathologic Function
T13	CHEM 748 764	corticosteroides
#11	AnnotatorNotes T13	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T14	PROC 767 786	terapias biológicas
#12	AnnotatorNotes T14	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
T15	PROC 813 829	test de embarazo
#13	AnnotatorNotes T15	C0032976; Pregnancy Tests; Diagnostic Procedure
T16	CHEM 730 746	inmunodepresivos
#14	AnnotatorNotes T16	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T17	CHEM 70 77	ABT-494
#15	AnnotatorNotes T17	C4308782; ABT-494; Organic Chemical · Pharmacologic Substance
T18	Date 13 17	2016
T19	LIVB 81 90	pacientes
#16	AnnotatorNotes T19	C0030705; Patients; Patient or Disabled Group
T20	LIVB 318 327	pacientes
#17	AnnotatorNotes T20	C0030705; Patients; Patient or Disabled Group
T21	LIVB 438 444	Hombre
#18	AnnotatorNotes T21	C0025266; Male population group; Population Group
T22	LIVB 447 452	mujer
#19	AnnotatorNotes T22	C0043210; Woman; Population Group
T23	Age 453 471	entre 18 y 75 años
T24	Date 537 549	hace 90 días
T25	Neg_cue 801 809	negativo
T26	LIVB 835 866	mujeres potencialmente fértiles
#20	AnnotatorNotes T26	C4324275; Woman of childbearing potential; Population Group
T29	PHYS 821 829	embarazo
#21	AnnotatorNotes T29	C0032961; Pregnancy; Organism Function
A1	Assertion T29 Negated
A3	Status T12 History_of
#22	AnnotatorNotes T2	C1096776; Multicenter Study; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#23	AnnotatorNotes T4	C0511730; Identify product efficacy and safety issues; Health Care Activity
T27	Spec_cue 843 857	potencialmente
T28	Quantifier_or_Qualifier 858 866	fértiles
A4	Assertion T28 Speculated
R1	Speculation Arg1:T27 Arg2:T28	
R2	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T28	
R3	Negation Arg1:T25 Arg2:T29	
R4	Experiences Arg1:T26 Arg2:T15	
R5	Causes Arg1:T16 Arg2:T12	
R6	Causes Arg1:T13 Arg2:T12	
R7	Causes Arg1:T14 Arg2:T12	
T30	Quantifier_or_Qualifier 633 650	severa / moderada
#24	AnnotatorNotes T30	C1299393; Moderate to severe; Qualitative Concept
R8	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T30	
T31	Quantifier_or_Qualifier 119 136	severa / moderada
#25	AnnotatorNotes T31	C1299393; Moderate to severe; Qualitative Concept
R9	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T31	
T32	Quantifier_or_Qualifier 352 368	Moderada a Grave
#26	AnnotatorNotes T32	C1299393; Moderate to severe; Qualitative Concept
R10	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T32	
R11	Experiences Arg1:T19 Arg2:T17	
R12	Experiences Arg1:T19 Arg2:T1	
T33	Quantifier_or_Qualifier 112 118	activa
#27	AnnotatorNotes T33	C0679217; Active State; Idea or Concept
R13	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T33	
T34	Quantifier_or_Qualifier 626 632	activa
#28	AnnotatorNotes T34	C0679217; Active State; Idea or Concept
R14	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T34	
T35	Observation 654 674	Respuesta inadecuada
#29	AnnotatorNotes T35	C1320680; Poor response to treatment; Finding
R15	Overlap Arg1:T35 Arg2:T16	
R16	Overlap Arg1:T35 Arg2:T13	
R17	Overlap Arg1:T35 Arg2:T14	
T36	Observation 687 707	pérdida de respuesta
#30	AnnotatorNotes T36	C5400193; Loss of therapeutic response; Finding
R18	Overlap Arg1:T36 Arg2:T16	
R19	Overlap Arg1:T36 Arg2:T13	
R20	Overlap Arg1:T36 Arg2:T14	
R21	Used_for Arg1:T3 Arg2:T5	
R22	Experiences Arg1:T20 Arg2:T3	
R23	Experiences Arg1:T20 Arg2:T6	
R24	Has_Age Arg1:T21 Arg2:T23	
R25	Has_Age Arg1:T22 Arg2:T23	
T37	CONC 478 491	momento basal
#31	AnnotatorNotes T37	C1442488; Baseline; Quantitative Concept
R26	Overlap Arg1:T23 Arg2:T37	
R27	Before Arg1:T9 Arg2:T24	
T38	CONC 562 575	momento basal
#32	AnnotatorNotes T38	C1442488; Baseline; Quantitative Concept
R28	Before Arg1:T9 Arg2:T38	
R29	Overlap Arg1:T8 Arg2:T38	
R30	Overlap Arg1:T8 Arg2:T24	
R32	Before Arg1:T10 Arg2:T8	
A2	Experiencer T26 Patient
A5	Experiencer T19 Patient
A6	Experiencer T20 Patient
A7	Experiencer T21 Patient
A8	Experiencer T22 Patient
T39	Result_or_Value 791 809	Resultado negativo
R31	Has_Result_or_Value Arg1:T15 Arg2:T39	
